Developing Live Biotherapeutics for Immuno-Oncology: Latest Preclinical Data and Mechanisms of Action
Date & Time
Wednesday, June 3, 2020, 12:15 PM - 12:40 PM
Delphine Lauté-Caly

• 4D pharma present their preclinical data demonstrating the ability of LBPs to offer a novel approach to immuno-oncology in monotherapy and combination settings through strong immunostimulatory profiles.

• Assess the selected LBP candidates that inhibit tumour growth across multiple preclinical models and how these could be applied

clinically in the future.

• Learn how 4D pharma were able to characterise the bioactive molecules involved in molecular mechanisms of action and develop drugs to target immuno-oncology.

Session Type
Virtual Session Link
On Demand